Original Research

Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (DextenzaTM): results of a qualitative survey

Gira JP, Sampson R, Silverstein SM, Walters TR, Metzinger JL, Talamo JH

Patient Preference and Adherence 2017, 11:487-494

Published Date: 8 March 2017